February 7, 2025
The widely used FAST acronym remains the best tool for helping bystanders recognize stroke symptoms, despite efforts to expand it to BE-FAST. A new study showed […]
February 6, 2025
Headache, including migraine, tension-type, trigeminal autonomic cephalalgia (TAC), and posttraumatic stress headache are significantly associated with both attempted and completed suicide, results of a large study […]
February 6, 2025
TOPLINE: Weekly nonpharmacologic intranasal kinetic oscillation stimulation is linked to a significant decrease in monthly headache days (MHDs) with moderate to severe intensity in patients with […]
February 5, 2025
Regular dental flossing is linked to a lower risk for ischemic stroke, primarily by reducing systemic inflammation, which can lead to atrial fibrillation (AF) increasing the […]
February 4, 2025
A new tool could potentially reduce epilepsy misdiagnoses by up to 70%, new research suggests. Known as EpiScalp, the tool uses algorithms trained on dynamic network […]
January 31, 2025
The US Food and Drug Administration (FDA) has approved a novel formulation combining rizatriptan and the nonsteroidal anti-inflammatory drug meloxicam (Symbravo, Axome Therapeutics) for the acute […]
January 31, 2025
The European Medicines Agency (EMA) announced it will review new safety data on the Alzheimer’s disease drug Leqembi (lecanemab). This follows a prior decision to recommend […]
January 31, 2025
The US Food and Drug Administration (FDA) has approved suzetrigine 50 mg tablets (Journavx, Vertex Pharmaceuticals), a first-in-class nonopioid analgesic for treatment of adults with moderate-to-severe […]
January 30, 2025
TOPLINE: Multiple sclerosis (MS) is associated with a 26% higher risk for mental illness during pregnancy and a 33% higher risk in the first postpartum year […]